Alembic Pharmaceuticals Limited (APLLTD) — Cash Flow Quality Index
Alembic Pharmaceuticals Limited (APLLTD) has a Cash Flow Quality Index of 2.18x as of September 2025. Operating cash flow of Rs4.03 Billion exceeds net income of Rs1.85 Billion, indicating high earnings quality where cash backs reported profits. Explore cash flow to debt ratio of Alembic Pharmaceuticals Limited to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Alembic Pharmaceuticals Limited Cash Flow Quality Index (2011–2025)
Historical Cash Flow Quality Index for Alembic Pharmaceuticals Limited across 15 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Alembic Pharmaceuticals Limited (APLLTD) cash flow conversion.
Annual Cash Flow Quality Index for Alembic Pharmaceuticals Limited (2011–2025)
Year-by-year earnings quality comparison for Alembic Pharmaceuticals Limited.
| Year | Quality Index | Operating CF (INR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.15x | Rs879.70 Million | Rs5.83 Billion | ▼ -88.4% |
| 2024 | 1.30x | Rs8.03 Billion | Rs6.16 Billion | ▼ -36.1% |
| 2023 | 2.04x | Rs7.24 Billion | Rs3.55 Billion | ▲ +129.2% |
| 2022 | 0.89x | Rs5.52 Billion | Rs6.20 Billion | ▼ -16.7% |
| 2021 | 1.07x | Rs14.63 Billion | Rs13.68 Billion | ▲ +138.1% |
| 2020 | 0.45x | Rs4.49 Billion | Rs10.00 Billion | ▼ -58.5% |
| 2019 | 1.08x | Rs8.12 Billion | Rs7.49 Billion | ▲ +87.7% |
| 2018 | 0.58x | Rs3.12 Billion | Rs5.41 Billion | ▲ +5.0% |
| 2017 | 0.55x | Rs2.89 Billion | Rs5.25 Billion | ▼ -44.7% |
| 2016 | 0.99x | Rs9.30 Billion | Rs9.36 Billion | ▲ +107.9% |
| 2015 | 0.48x | Rs1.72 Billion | Rs3.59 Billion | ▼ -37.1% |
| 2014 | 0.76x | Rs2.36 Billion | Rs3.11 Billion | ▼ -40.7% |
| 2013 | 1.28x | Rs2.65 Billion | Rs2.06 Billion | ▲ +46.8% |
| 2012 | 0.87x | Rs1.41 Billion | Rs1.61 Billion | ▼ -2.9% |
| 2011 | 0.90x | Rs961.81 Million | Rs1.07 Billion | — |